NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 20 04:00PM ET
1.18
Dollar change
-0.06
Percentage change
-4.84
%
IndexRUT P/E- EPS (ttm)-2.22 Insider Own29.34% Shs Outstand31.35M Perf Week-7.09%
Market Cap37.00M Forward P/E- EPS next Y-2.31 Insider Trans-19.70% Shs Float22.16M Perf Month-5.60%
Enterprise Value-109.12M PEG- EPS next Q-0.57 Inst Own56.83% Short Float4.72% Perf Quarter-77.04%
Income-83.75M P/S- EPS this Y7.47% Inst Trans-41.33% Short Ratio1.35 Perf Half Y-83.14%
Sales0.00M P/B0.23 EPS next Y-4.89% ROA-56.42% Short Interest1.05M Perf YTD-80.40%
Book/sh5.12 P/C0.25 EPS next 5Y3.46% ROE-62.41% 52W Range1.05 - 10.16 Perf Year-82.85%
Cash/sh4.77 P/FCF- EPS past 3/5Y-45.20% -74.96% ROIC-51.44% 52W High-88.39% Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- 52W Low12.38% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM22.94% Oper. Margin- Volatility3.33% 4.00% Perf 10Y-
Dividend Ex-Date- Quick Ratio11.17 Sales Y/Y TTM- Profit Margin- RSI (14)41.33 Recom1.22
Dividend Gr. 3/5Y- - Current Ratio11.17 EPS Q/Q29.68% SMA20-1.34% Beta1.55 Target Price10.71
Payout- Debt/Eq0.02 Sales Q/Q- SMA50-13.63% Rel Volume0.32 Prev Close1.24
Employees78 LT Debt/Eq0.02 EarningsMay 14 AMC SMA200-76.96% Avg Volume777.22K Price1.18
IPONov 15, 2022 Option/ShortNo / Yes EPS/Sales Surpr.20.62% - Trades Volume251,221 Change-4.84%
Date Action Analyst Rating Change Price Target Change
May-05-25Resumed Piper Sandler Overweight $6
Jan-31-25Initiated KeyBanc Capital Markets Overweight
Sep-16-24Upgrade Ladenburg Thalmann Neutral → Buy $16
Apr-29-24Downgrade Ladenburg Thalmann Buy → Neutral
Mar-01-24Initiated JMP Securities Mkt Outperform $14
Dec-15-23Resumed Jefferies Buy $17 → $12
Oct-05-23Initiated Maxim Group Buy
Jun-02-23Initiated Oppenheimer Outperform $25
May-08-23Initiated BMO Capital Markets Outperform $25
Apr-27-23Initiated Ladenburg Thalmann Buy $22
May-17-25 12:30PM
May-14-25 04:10PM
May-05-25 09:55AM
Apr-28-25 12:23PM
Apr-25-25 08:00AM
11:00AM Loading…
Apr-24-25 11:00AM
Apr-23-25 01:41PM
01:28PM
Apr-22-25 11:19AM
Apr-14-25 09:35AM
Apr-07-25 04:05PM
Mar-28-25 12:00PM
09:35AM
Mar-27-25 05:44PM
Mar-19-25 08:00AM
08:16AM Loading…
Feb-06-25 08:16AM
04:54AM
Feb-05-25 03:45PM
08:00AM
Nov-13-24 07:00AM
Oct-17-24 08:00AM
Oct-16-24 04:00PM
Oct-12-24 08:28AM
Oct-11-24 08:00AM
Sep-14-24 03:10AM
Sep-10-24 08:00AM
Sep-09-24 07:00AM
Aug-15-24 09:40AM
Aug-13-24 08:00AM
Jun-21-24 09:40AM
09:40AM Loading…
Jun-05-24 09:40AM
May-29-24 08:00AM
May-28-24 09:47AM
May-20-24 09:40AM
May-14-24 01:54PM
08:00AM
May-10-24 08:50AM
Apr-29-24 07:08AM
Apr-24-24 04:01PM
Apr-16-24 08:01PM
Apr-10-24 08:00AM
Apr-09-24 10:32AM
07:00AM
Mar-30-24 05:31AM
Mar-28-24 12:52PM
08:00AM
Mar-05-24 04:30PM
Mar-04-24 08:00AM
Feb-27-24 08:00AM
Feb-08-24 08:00AM
Feb-06-24 08:00AM
Jan-12-24 04:00PM
Jan-04-24 08:00AM
Jan-03-24 08:00AM
Nov-28-23 08:00AM
Nov-21-23 08:00AM
08:00AM
Nov-09-23 08:01AM
Oct-16-23 08:00AM
Sep-28-23 04:05PM
Sep-19-23 04:32PM
Sep-05-23 04:05PM
Aug-30-23 08:00AM
Aug-17-23 04:00PM
Aug-11-23 07:00AM
Aug-08-23 12:38PM
Jul-20-23 08:00AM
Jun-29-23 04:49PM
Jun-22-23 04:00PM
Jun-02-23 08:00AM
May-09-23 10:43AM
08:00AM
08:00AM
May-07-23 08:17AM
Apr-25-23 08:00AM
Apr-24-23 08:00AM
Apr-18-23 08:00AM
Mar-28-23 08:00AM
Mar-06-23 08:00AM
Feb-27-23 08:00AM
Feb-15-23 05:40AM
Feb-14-23 10:15AM
Jan-22-23 03:31PM
Nov-14-22 10:16PM
Acrivon Therapeutics, Inc. develops drugs for clinical treatment. Its unique precision medicine platform is Acrivon Predictive Precision Proteomics (AP3). AP3 is used to generate proprietary OncoSignature companion diagnostics to identify patients who will benefit from the medicine. The company was founded by Peter Blume-Jensen and Kristina Masson in 2018 and is headquartered in Watertown, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PERCEPTIVE ADVISORS LLC10% OwnerApr 30 '25Sale1.41437,881617,4123,403,025May 01 07:07 PM
PERCEPTIVE ADVISORS LLC10% OwnerMay 01 '25Sale1.34298,886400,5073,104,139May 01 07:07 PM
PERCEPTIVE ADVISORS LLC10% OwnerApr 25 '25Sale1.951,054,6692,056,6054,306,189Apr 29 07:26 PM
PERCEPTIVE ADVISORS LLC10% OwnerApr 29 '25Sale1.41250,000352,5003,840,906Apr 29 07:26 PM
PERCEPTIVE ADVISORS LLC10% OwnerApr 28 '25Sale1.56215,283335,8414,090,906Apr 29 07:26 PM